CannTrust Halts Sales as Health Canada Investigation Expands

Published on July 12, 2019 · Last updated July 28, 2020

Patients of licensed producer CannTrust might have been mistaken if they thought their computer was glitching starting Wednesday night. Logging into the company’s online shopping portal brought up a blank screen instead of the dozens of cannabis products patients typically have access to.

And if patients were to call the toll-free number listed on the page, they would find out from a customer service representative that the company had placed some sort of hold on all sales of cannabis from the company’s warehouse to medical patients and provincially-authorized recreational distributors.Join the Leafly Canada CommunityThat followed a bombshell earlier this week. As first reported by the Globe and Mail, a former employee of CannTrust that worked in the company’s Pelham, Ontario facility wrote a letter to Health Canada indicating that the company was growing in unlicensed rooms and that employees at the company had moved white poly sheets around to make it seem as the unlicensed rooms were empty.

Two days later, Health Canada showed up to the facility, and has been investigating the situation ever since.

On Wednesday, the company told media that it had grown approximately 5,000 kilograms in unlicensed rooms from October 2018 to March 2019. There were reports that some of the cannabis had already been sold to provinces and provincially-authorized distributors.

CannTrust then announced on Thursday it would form an independent special committee to investigate the entire situation.

It took another handful of hours—11:32 p.m. on Thursday night, to be exact—before CannTrust sent an email to patients explaining the situation.

“We are currently working on a facility review with Health Canada and as a precaution, we have implemented a voluntary hold on the sale of our medical products as of July 10th, 2019,” the message from CEO Peter Aceto read.

The email didn’t mention unlicensed rooms or the events that led up to the voluntary hold but it did say that all products sold had passed quality control testing at Health Canada approved lab’s “as well as CannTrust’s own quality control processes and safety reviews.”

At least one store, AMERI in downtown Toronto, said on Thursday that while its stock of Liiv products is low, they still have some remaining.

CannTrust’s stock has also took a tumble. It was as high as $13.45 at the end of March 2019, but had since declined to around $6.50 at the beginning of July. When the news broke a few days later, the stock plummeted and went as low as $3.52 midday Friday.

CannTrust is not the first licensed producer of cannabis to be in hot water over the production or sales of illicit cannabis.

Bonify had their license suspended late last year after they admitted that someone at the company had purchased illegal cannabis and later resold it. Similarly, Health Canada in late 2017 threatened to revoke the license of Agrima Botanicals, which reportedly had conducted illicit production of cannabis.

It’s not yet known how long this hold will be in place. As required under the Cannabis Regulations, CannTrust is facilitating the transfer of medical documents to other federally-licensed sellers in the event patients registered with them would like to switch to another provider.

Shop highly rated stores near you

Showing you stores near
See all stores
Harrison Jordan
Harrison Jordan
Harrison Jordan is a graduate of Osgoode Hall Law School in Toronto and enjoys reading and writing about the regulatory affairs of cannabis in Canada and around the world.
View Harrison Jordan's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play

The material provided on Leafly is intended for educational and informational purposes only. Leafly is not engaged in rendering medical service or advice and the information provided is not a substitute for a professional medical opinion. If you have a medical problem, please contact a qualified health professional.

© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.